Phase 3 Readout~month

Phase 3 Topline: A Multicenter, Randomized, Phase 3 Study to Assess the Efficacy and Safety of INtratumorally Adminis

Indication
Sarcoma,Soft Tissue

Other upcoming events for INTS

Patent ExpiryPatent/Exclusivity Expiry: HALAVEN

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 3 Topline: A Multicenter, Randomized, Phase 3 Study to Assess the Efficacy and Safety of INtratumorally Adminis — INTS Phase 3 Readout | BioSniper